1. . 2017. Prevalence and architecture of de novo mutations in developmental disorders. In Nature, 542, 433-438. doi:10.1038/nature21062. https://pubmed.ncbi.nlm.nih.gov/28135719/
2. Duan, H L, Peng, J, Pang, N, Guang, S Q, Yin, F. . [A case of Okur-Chung syndrome caused by CSNK2A1 gene variation and review of literature]. In Zhonghua er ke za zhi = Chinese journal of pediatrics, 57, 368-372. doi:10.3760/cma.j.issn.0578-1310.2019.05.010. https://pubmed.ncbi.nlm.nih.gov/31060130/
3. Kataoka, Keisuke, Nagata, Yasunobu, Kitanaka, Akira, Shimoda, Kazuya, Ogawa, Seishi. 2015. Integrated molecular analysis of adult T cell leukemia/lymphoma. In Nature genetics, 47, 1304-15. doi:10.1038/ng.3415. https://pubmed.ncbi.nlm.nih.gov/26437031/
4. Zhuri, Drenushe, Dusenkalkan, Fulya, Tunca Alparslan, Guzin, Gurkan, Hakan. 2023. A Case of Okur-Chung Neurodevelopmental Syndrome with a Novel, de novo Variant on the CSNK2A1 Gene in a Turkish Patient. In Molecular syndromology, 15, 43-50. doi:10.1159/000530585. https://pubmed.ncbi.nlm.nih.gov/38357263/
5. Jiang, Chao, Ma, Zhenghong, Zhang, Guoan, Du, Qin, Wang, Weibo. 2019. CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway. In Cancer management and research, 11, 10135-10143. doi:10.2147/CMAR.S222620. https://pubmed.ncbi.nlm.nih.gov/31819646/
6. Shui, Bing, Beyett, Tyler S, Chen, Zhengyi, Ventura, Andrea, Haigis, Kevin M. 2023. Oncogenic K-Ras suppresses global miRNA function. In Molecular cell, 83, 2509-2523.e13. doi:10.1016/j.molcel.2023.06.008. https://pubmed.ncbi.nlm.nih.gov/37402366/
智鼠故事 
